Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

France Rejects Merck's COVID-19 Pill: How Bad Is the News?

TheMotleyFool

0 0

France Rejects Merck's COVID-19 Pill: How Bad Is the News?

At least one major country won't allow the use of Merck's (NYSE: MRK) COVID-19 pill molnupiravir. French regulators announced in December that the therapy would not be authorized. In this Motley Fool Live video recorded on Dec. 15, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how bad this news is for Merck.

Source Fool.com

Like: 0

MRK

Share